library.onepin.app/astaxanthin Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider
Metabolic Dietary supplement

Astaxanthin

AstaReal · AstaPure

4-12mg daily – 12 mg Oral Once daily with fattiest meal

Astaxanthin is a red-orange xanthophyll carotenoid produced primarily by the freshwater microalga Haematococcus pluvialis under stress conditions. It accumulates up the marine food chain - giving salmon, krill, shrimp, and flamingos their characteristic pink-red color. Among carotenoids, astaxanthin has unique structural features (ketone groups at the terminal rings) that make it dramatically more potent as an antioxidant than beta-carotene, lycopene, or vitamin E.

Quick Start
Route
Oral
Start low
4-12mg Oral
Frequency
Once daily with fattiest meal
Timing
Anytime

Take with a meal containing fat - absorption is 3-fold higher with dietary fat. Single daily dose adequate due to long tissue half-life. Morning dosing typical. Effects build over weeks - be patient.

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Conservative start
4-12mg daily · Oral · Once daily with fattiest meal
conservative starter
4-12mg daily
Once daily with fattiest meal
Standard
Systemic Antioxidant
12 mg · Oral · Daily
human study · Fassett & Coombes 2011 (Mar Drugs)
Highly fat-soluble; must be taken with fats for absorption.
12 mg
Daily
01

How it works

Astaxanthin is the most potent natural singlet oxygen quencher known. Singlet oxygen is generated by UV exposure, mitochondrial respiration, and inflammation. By quenching singlet oxygen, astaxanthin prevents lipid peroxidation in cell membranes, protein oxidation, and DNA damage.

Membrane-spanning antioxidant: astaxanthin's unique molecular structure allows it to span the entire phospholipid bilayer with polar ends in the aqueous compartments and the carotenoid backbone in the lipid layer. This protects both compartments from oxidation simultaneously - unlike vitamin E (lipid only) or vitamin C (aqueous only).

Anti-inflammatory: astaxanthin downregulates NF-kB signaling, reducing TNF-alpha, IL-1, and IL-6 production. It inhibits 5-lipoxygenase and reduces leukotriene production.

Skin: dermal accumulation provides UV protection (similar mechanism to plant melanin), prevents matrix metalloproteinase degradation of collagen, and reduces wrinkle formation. Works as 'internal sunscreen' - several weeks of supplementation increases minimal erythemal dose by ~20-40%.

Eye: crosses blood-retinal barrier and accumulates in macula. Reduces eye fatigue, improves accommodation, and supports macular pigment integrity.

Cardiovascular: reduces LDL oxidation (oxidized LDL is the atherogenic form), improves HDL function, and supports endothelial NO production.

Mitochondrial: protects mitochondrial membranes from ROS-induced damage, supporting cellular energetics.

Brain: crosses BBB and accumulates in neurons. Animal models show neuroprotection in stroke, Alzheimer's, and Parkinson's models.

02

What to expect

Early
Days 1–7

Weeks 1-4: Tissue accumulation begins, mild subjective effects.

03

Evidence

HumanModerate
AnimalPresent
In-vitroPresent

Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.

Dose/route: participants received a daily oral capsule containing 4 mg astaxanthin, matching the low end of the card’s 4-12 mg/day range.

They were assigned to the astaxanthin group supplemented with a capsule containing 4 mg of astaxanthin or the placebo group.

The Protective Role of Astaxanthin for UV-Induced Skin Deterioration in Healthy People-A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients · 2018 · PMID 29941810

Evidence scope. Human, healthy Japanese volunteers (n=23), algal (natural) astaxanthin, oral capsule; healthy-population dosing precedent only.

Dose safety boundary: approved/recommended doses across jurisdictions ranged from 2 to 24 mg/day.

Recommended or approved doses varied in different countries and ranged between 2 and 24 mg.

Astaxanthin: How much is too much? A safety review. Phytotherapy research : PTR · 2019 · PMID 31788888

Evidence scope. Human regulatory/safety review; the 2-24 mg range spans both natural and synthetic astaxanthin approvals, and the review itself warns the two forms should not be treated as interchangeable for safety inference.

Dose/effect: clinical skin data supported 3-6 mg/day supplementation.

Overall, there is some clinical data to support the benefits of astaxanthin supplementation (in the range of 3 to 6 mg/d) on skin health, especially for photoaged skin.

Effects of Astaxanthin Supplementation on Skin Health: A Systematic Review of Clinical Studies. Journal of dietary supplements · 2021 · PMID 32202443

Evidence scope. Human systematic review of ~11 mostly small trials, predominantly healthy Japanese female subjects, photoaged-skin focus; several trials industry-funded.

Primary safety: the skin-health review reported no serious adverse events.

No serious adverse events were reported in any of the studies.

Effects of Astaxanthin Supplementation on Skin Health: A Systematic Review of Clinical Studies. Journal of dietary supplements · 2021 · PMID 32202443

Evidence scope. Human, same small/narrow-demographic, partly industry-funded trial base as the companion 3-6 mg/day row; absence of serious AEs across those specific studies, not a general safety finding.

Mechanism boundary: preclinical work links astaxanthin to Keap1-Nrf2/HO-1 signaling and ferroptosis inhibition.

Consistently, administration of astaxanthin protected mice against LPS-induced ALI and significantly decreased the extent of lung edema, inflammatory cells infiltration, and ferroptosis in vivo, and Keap1-Nrf2/HO-1 pathway is involved in astaxanthin inhibits LPS-induced ALI and ferroptosis.

Astaxanthin attenuates ferroptosis via Keap1-Nrf2/HO-1 signaling pathways in LPS-induced acute lung injury. Life sciences · 2022 · PMID 36252699

Evidence scope. Preclinical only (mice + RAW264.7 macrophage cell line); astaxanthin source/form (natural vs synthetic) is not specified in the abstract; no human data.

04

Interactions & stacking

Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.

Documented together

Most supplementsExcellent safety profile; few negative interactions.
Vitamin E (Mixed Tocopherols)Both lipid-phase antioxidants; astaxanthin protects vitamin E from oxidation, extending its half-life. Synergistic for cardiovascular and skin applications.
Lutein + ZeaxanthinAll three accumulate in eye tissue. Synergistic for macular protection and eye health. Common in eye support formulas.
Omega-3 Fatty AcidsAstaxanthin protects omega-3 PUFAs from peroxidation. Krill oil naturally provides both - convenient synergy.

Keep separate

Antihypertensives (mild interaction)Astaxanthin has modest BP-lowering effect - additive with antihypertensives. Not contraindicated, but monitor BP.
Beta-carotene/vitamin A (theoretical)May compete for absorption at very high doses of either. Not a clinical concern at typical supplement doses.
Anticoagulants (theoretical)Mild antiplatelet effect at high doses - discuss with prescriber if on anticoagulants.

Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.

05

Pharmacokinetics

Illustrative plasma concentration · 3 d
Half-life
~16-21 hours

Plasma - long for a carotenoid. Tissue half-life much longer (weeks).

Peak · Tmax
~6-9 hours

Oral with fat-containing meal.

Elimination

Plasma clearance ~3-4 days. Tissue accumulation continues for weeks of consistent dosing.

Bioavailability
~10-50%

With fat-containing meal. Without fat: <5%. Significantly improved by phospholipid carriers (krill oil).

Duration of action

Acute antioxidant: 24+ hours per dose. Tissue accumulation effects on skin, eye, cardiovascular: build over 4-16 weeks.

Clearance

Hepatic metabolism (limited - astaxanthin is largely excreted unchanged or as conjugates). Biliary excretion. Tissue retention is significant.

Storage. Store at room temperature (20-25C) in a cool, dry place. Protect from light and heat - astaxanthin is sensitive to oxidation and degradation. Softgels in opaque containers shelf-stable 1-2 years. Refrigeration extends shelf life.

06

Regulatory status

Classified as a dietary supplement in the US - no prescription required. Widely available. Used as an animal feed additive (salmon coloring) for decades with safety record. No FDA-approved medical indication.

Put it to work

Calculate, log & track

Open Astaxanthin straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open Astaxanthin in the app →

Go deeper

The guide & community

The complete Astaxanthin walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community

Track it in OnePin. Log vials, draws, and protocols in the app.